Embedded Files
Título: Dos realidades del VIH: Algunos accederían a terapias avanzadas y otros enfrentarían barreras y demoras
Source
Source
En el marco del Día Mundial de la Lucha contra el VIH/SIDA, un destacado panel organizado por la Revista Medicina y Salud Pública reunió a tres voces expertas de Latinoamérica para analizar los retos y avances en la atención del VIH en la región.
Bajo la moderación de la Dra. Lenisse Candelario, participaron el Dr. José Ledesma Báez, especialista en enfermedades infecciosas de República Dominicana; el Dr. Julio Bacó, vicepresidente de la Asociación Médica de Especialistas en VIH de Puerto Rico; y el Dr. Pablo Andrés Moncada, médico infectólogo de Colombia.
En este espacio, el Dr. Moncada expuso una perspectiva con matices sobre el estado del VIH en Colombia, abordando los avances clínicos y las brechas estructurales que, según su diagnóstico, crean dos realidades paralelas para quienes viven con el virus en el país.
"El VIH es la enfermedad que ha tenido más avances en los últimos 30 años, aunque fue una enfermedad que en los ochentas era una sentencia de muerte, como lo vivieron muchas personas en todo el mundo".
Ese progreso, según el especialista, se debe al " activismo y a la disposición de la industria farmacéutica para desarrollar retrovirales, pues, hoy en día tenemos medicamentos, dos medicamentos en una sola tableta y ya próximamente dos medicamentos inyectables".
Sin embargo, expuso que el acceso a esos logros no es parejo. Al ahondar en la realidad latinoamericana, señaló que "como Latinoamérica, en la mayoría de tecnologías tenemos un rezago y nuestros países, yo estoy seguro que Puerto Rico y República Dominicana, tal vez Puerto Rico menos, tienen ese rezago".
DeepL
DeepL
As part of World AIDS Day, a prominent panel organized by Medicina y Salud Pública magazine brought together three expert voices from Latin America to analyze the challenges and advances in HIV care in the region.
Moderated by Dr. Lenisse Candelario, the panel included Dr. José Ledesma Báez, an infectious disease specialist from the Dominican Republic; Dr. Julio Bacó, vice president of the Medical Association of HIV Specialists of Puerto Rico; and Dr. Pablo Andrés Moncada, an infectious disease physician from Colombia.
In this space, Dr. Moncada presented a nuanced perspective on the state of HIV in Colombia, addressing clinical advances and structural gaps that, according to his diagnosis, create two parallel realities for those living with the virus in the country.
“HIV is the disease that has seen the most progress in the last 30 years, even though in the 1980s it was a death sentence, as many people around the world experienced.”
This progress, according to the specialist, is due to “activism and the willingness of the pharmaceutical industry to develop retrovirals, because today we have medications, two medications in a single tablet, and soon two injectable medications.”
However, he explained that access to these achievements is not equal. Delving into the reality of Latin America, he pointed out that “in Latin America, we lag behind in most technologies, and I am sure that our countries, Puerto Rico and the Dominican Republic, perhaps Puerto Rico less so, are lagging behind.”
ChatGPT
ChatGPT
In the context of World AIDS Day, a distinguished panel organized by Medicina y Salud Pública Magazine brought together three expert voices from Latin America to analyze the challenges and progress in HIV care in the region.
Moderated by Dr. Lenisse Candelario, the panel featured Dr. José Ledesma Báez, an infectious disease specialist from the Dominican Republic; Dr. Julio Bacó, vice president of the Medical Association of HIV Specialists of Puerto Rico; and Dr. Pablo Andrés Moncada, an infectious disease physician from Colombia.
During the discussion, Dr. Moncada presented a nuanced perspective on the state of HIV in Colombia, addressing clinical advances and structural gaps that, according to his assessment, create two parallel realities for people living with the virus in the country.
“HIV is the disease that has seen the most progress in the last 30 years, even though in the 1980s it was a death sentence, as many people around the world experienced.”
This progress, according to the specialist, is due to “activism and the willingness of the pharmaceutical industry to develop antiretrovirals, since today we have medications—two drugs in a single pill, and soon, two injectable medications.”
However, he explained that access to these advances is not equal. Delving into the Latin American reality, he pointed out that “as Latin America, in most technologies we are behind, and our countries—I’m sure that Puerto Rico and the Dominican Republic, perhaps Puerto Rico less so—have that lag.”
Referencias por IA:
Pan American Health Organization (PAHO) / World Health Organization (WHO) — “Experts Analyze Obstacles to Universal HIV Treatment in Latin America and the Caribbean”: este informe aborda los obstáculos estructurales para lograr cobertura universal del tratamiento antirretroviral (ART) en la región: fallas en los sistemas de salud, distribución de fármacos, interrupciones (“stock-outs”), problemas de abastecimiento.
Revisión académica: “The HIV care continuum in Latin America: challenges and opportunities” — artículo que analiza el “continuum de atención” del VIH en Latinoamérica: aunque muchas personas reciben tratamiento, los sistemas de salud son deficientes en varias etapas, desde diagnóstico hasta supresión viral. Indica que muchas personas llegan tarde al tratamiento, y en varios países solo una fracción logra supresión viral.
Informe reciente de salud pública 2025: Organización Panamericana de la Salud (OPS) — “Diagnóstico temprano del VIH podría reducir muertes relacionadas con el sida en América Latina y el Caribe”: señala que aproximadamente un tercio de las personas con VIH en la región se diagnostican demasiado tarde, lo que incrementa las muertes por sida. Esto evidencia que aún hay graves brechas en diagnóstico, tratamiento oportuno y atención integral.
Reporte de cobertura desigual: un artículo reciente de prensa señala que la cobertura de tratamiento antirretroviral (TAR) en América Latina alcanza cerca del 71% de las personas con VIH, un nivel inferior al promedio global, con disparidades especialmente altas para niños, mujeres embarazadas, poblaciones vulnerables (hombres que tienen sexo con hombres, personas trans, trabajadoras sexuales).
Análisis sobre persistencia de desigualdades sociales y estructurales: un artículo académico-discursivo revisa cómo factores sociales, estigma, desigualdades estructurales, discriminación, acceso desigual a servicios de salud y falta de inversión afectan de forma persistente la prevención y tratamiento del VIH en América Latina, limitando el alcance real de los avances técnicos.
References by AI:
Pan American Health Organization (PAHO) / World Health Organization (WHO) — “Experts Analyze Obstacles to Universal HIV Treatment in Latin America and the Caribbean”: This report addresses the structural obstacles to achieving universal antiretroviral therapy (ART) coverage in the region: failures in health systems, drug distribution, stockouts, and supply problems.
Academic Review: “The HIV Care Continuum in Latin America: Challenges and Opportunities” — This article analyzes the HIV care continuum in Latin America: Although many people receive treatment, health systems are deficient at various stages, from diagnosis to viral suppression. It indicates that many people start treatment late, and in several countries, only a fraction achieve viral suppression.
Recent Public Health Report 2025: Pan American Health Organization (PAHO) — “Early HIV Diagnosis Could Reduce AIDS-Related Deaths in Latin America and the Caribbean”: notes that approximately one-third of people with HIV in the region are diagnosed too late, increasing AIDS-related deaths. This highlights the continued serious gaps in diagnosis, timely treatment, and comprehensive care.
Report on Unequal Coverage: a recent press article indicates that antiretroviral therapy (ART) coverage in Latin America reaches approximately 71% of people living with HIV, a level below the global average, with particularly high disparities for children, pregnant women, and vulnerable populations (men who have sex with men, transgender people, and sex workers).
Analysis of Persistent Social and Structural Inequalities: an academic-discursive article reviews how social factors, stigma, structural inequalities, discrimination, unequal access to health services, and lack of investment persistently affect HIV prevention and treatment in Latin America, limiting the true impact of technological advances.
Reflection:
Both tools provided valuable support, yet each contributed in different ways to the accuracy, style, and overall quality of the final translation. Comparing their outputs allowed me to better understand their strengths and limitations, as well as the importance of the translator’s role in evaluating and refining machine-generated content.
Overall, the use of DeepL and ChatGPT significantly supported my translation process by offering accuracy, fluency, and stylistic alternatives. However, these tools do not replace the critical analysis and expertise of a human translator. Instead, they function as powerful assistants that help streamline the work while still requiring careful post-editing. This reflection reinforces the idea that effective translation today involves a combination of technological tools and human linguistic competence.
Page updated
Google Sites
Report abuse